Fundraising Fox
Jacques Theurillat
InvestorPartner at Sofinnova Partners
Paris, France
Writes $100K – $5M checks · typically $1.5M
Find your path to Jacques
Sign up to see every warm intro you have to Jacques
- Paths you didn't know you had: your email and LinkedIn already hold routes to Jacques. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Jacques joined Sofinnova Partners in 2017 as a Partner in the Crossover Strategy, bringing extensive experience in biopharmaceutical operations and both private and public investing. He co-founded and managed Ares Life Sciences in 2008, deploying €1.25 billion across six life sciences companies, and previously spent nearly 20 years at the Serono pharmaceutical group in senior roles including deputy CEO, CFO, and head of strategic corporate development.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
Bronchus Technologies IncEsaote SpaEuromedic International BVGreer IncSanthera PharmaceuticalsStallergenes SA
Per the firm's website.
Colleagues at Sofinnova Partners
Network3
Investors connected to Jacques in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jacques Theurillat?
- Jacques joined Sofinnova Partners in 2017 as a Partner in the Crossover Strategy, bringing extensive experience in biopharmaceutical operations and both private and public investing. He co-founded and managed Ares Life Sciences in 2008, deploying €1.25 billion across six life sciences companies, and previously spent nearly 20 years at the Serono pharmaceutical group in senior roles including deputy CEO, CFO, and head of strategic corporate development.
- Where does Jacques Theurillat work?
- Jacques Theurillat is Partner at Sofinnova Partners.
- What does Jacques Theurillat invest in?
- Jacques Theurillat invests in Biotech.
- What check size does Jacques Theurillat write?
- Jacques Theurillat typically writes checks of $100K – $5M.
- What companies has Jacques Theurillat invested in?
- Investments tracked here include Bronchus Technologies Inc, Esaote Spa, Euromedic International BV, Greer Inc, Santhera Pharmaceuticals, Stallergenes SA.
About this profile. Compiled from public sources — Sofinnova Partners's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights